CEL-SCI Corporation news

   Watch this stock
Showing stories 51 - 60 of about 88   

Articles published

CVM 1.80 -0.01 (-0.55%)
price chart
CEL-SCI Co. (CVM) Sees Large Increase in Short Interest
CEL-SCI Co. (NYSEAMERICAN:CVM) saw a large growth in short interest during the month of January. As of January 12th, there was short interest totalling 759,737 shares, a growth of 48.9% from the December 29th total of 510,101 shares.
Chilton Investment Co Cut Jpmorgan Chase & Co (JPM) Stake By $7.81 Million ...
Cel-sci Corporation ($0.001 Par Value (NYSEAMERICAN:CVM) had a decrease of 15.26% in short interest. CVM's SI was 643,800 shares in February as released by FINRA.
Insider Selling: CEL-SCI Co. (NYSEAMERICAN:CVM) Insider Sells 8192 Shares of Stock
CEL-SCI logo CEL-SCI Co. (NYSEAMERICAN:CVM) insider Eyal Talor sold 8,192 shares of CEL-SCI stock in a transaction on Monday, January 22nd.
Greatmark Investment Partners Has Decreased By $929082 Its Apple (AAPL ...
Cel Sci Corporation (NYSEAMERICAN:CVM) had a decrease of 11.83% in short interest. CVM's SI was 462,000 shares in February as released by FINRA.
West Nile Virus Infections Medicine – Market Size, Growth, Research, Forecasts ...
It provides information on trends and developments, focuses on markets and materials, capacities, technologies, CAPEX cycle and the changing structure of the Global West Nile Virus Infections Medicine Market.
CEL-SCI Co. (CVM) Sees Large Decline in Short Interest
CEL-SCI Co. (NYSEAMERICAN:CVM) saw a significant decline in short interest during the month of December. As of December 29th, there was short interest totalling 510,101 shares, a decline of 3.2% from the December 15th total of 526,760 shares.
Investors Catching Stocks JPMorgan Chase & Co. (JPM)
CEL-SCI Corporation (NYSEAMERICAN:CVM) has declined 77.57% since February 21, 2017 and is downtrending. It has outperformed by 17.04% the S&P500.
(NYSE:JPM) Shares Bought by Private Wealth Partners LLC
Adage Capital Partners Gp Llc, which manages about $41.15B US Long portfolio, upped its stake in Arconic Inc by 334,924 shares to 625,324 shares, valued at $15.56M in 2017Q3, according to the filing.
Global Poxviridae Infections Drug Market Outlook 2018- Bavarian Nordic A/S ...
The research covers the current market size of the Global Poxviridae Infections Drug market and its growth rates based on 5 year history data along with company profile of key players/manufacturers such as Bavarian Nordic A/S, BioFactura, Inc., CEL-SCI ...
Team, Inc. (TISI) Reaches $18.15 After 8.00% Up Move; Cel Sci (NYSEAMERICAN ...
Cel Sci Corporation (NYSEAMERICAN:CVM) had a decrease of 11.83% in short interest. CVM's SI was 462,000 shares in February as released by FINRA.